Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 292337011000036113 | agalsidase beta 5 mg injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 292339011000036118 | agalsidase beta 5 mg injection, 5 mg vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| agalsidase beta 5 mg injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| agalsidase beta 5 mg injection, vial | Is a | agalsidase beta | true | Inferred relationship | Some | ||
| agalsidase beta 5 mg injection, vial | has intended active ingredient | agalsidase beta | true | Inferred relationship | Some | 1232880512 | |
| agalsidase beta 5 mg injection, vial | has Australian BoSS | agalsidase beta | true | Inferred relationship | Some | 1232880512 | |
| agalsidase beta 5 mg injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| agalsidase beta 5 mg injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1232880513 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fabrazyme 5 mg powder for injection, 5 mg vial | Is a | True | agalsidase beta 5 mg injection, vial | Inferred relationship | Some | |
| agalsidase beta 5 mg injection, 1 vial | has MPUU | True | agalsidase beta 5 mg injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR